New editorial: 2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidemias – Advancing evidence-based care through innovation

The 2025 Focused Update of the ESC/EAS Guidelines for the management of dyslipidemias, now published jointly in Atherosclerosis [1] and the European Heart Journal, signifies further evolution of contemporary lipid management. This update from the 2019 dyslipidemia guidelines [2] synthesizes the most compelling evidence from major randomized controlled trials and meta-analyses published since 2019, bringing changes to clinical management of dyslipidemias.

[1]
Mach F, Koskinas KC, Roeters van Lennep JE, et al. Focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias. Atherosclerosis 2025. https://doi.org/10.1016/j.atherosclerosis.2025.120479
[2]
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis 2019;290:140–205. https://doi.org/10.1016/j.atherosclerosis.2019.08.014.